TACC1 and prostate adenocarcinoma: Through DE analysis between tumors in the TCGA-PRAD cohort with lower expression of RARG and TACC1 (also a miR-96 target) and high expression of miR-96 (low RARG/low TACC1/high miR-96), compared to the reverse, we previously identified that altered SOX15 gene expression is significantly associated with worse disease-free survival.